| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Anthony Scaramucci SkyBridge Capital II LLC | 200,000 | $12,000 | $3,180 | -$8,820 | -73.5% |
| BO Brian Oliveira Clear Street Group Inc. | 311,566 | $11,653 | $4,953.9 | -$6,699.1 | -57.49% |
Amir Ali Monsefi Aire Advisors LLC | 13,065 | $573.55 | $207.73 | -$365.82 | -63.78% |
Michael Byun SageView Advisory Group LLC | 11,065 | $386.72 | $159.34 | -$227.38 | -58.8% |
Jae Cho Marex Group plc | 10,000 | $374 | $159 | -$215 | -57.49% |
| Diversified REITs Industry | Real Estate Sector | Jack Kendrick Heilbron CEO | NASDAQ (CM) Exchange | 74102L113 CUSIP |
| US Country | 15 Employees | - Last Dividend | - Last Split | 24 Jan 2022 IPO Date |
Presidio operates as a diversified Real Estate Investment Trust (REIT), specializing in model home properties which are primarily triple-net leased to homebuilders alongside its investments in office, industrial, and retail properties. With a strategic focus on geographic clustering, Presidio aims to leverage economies of scale to efficiently manage its real estate portfolio, though this approach also exposes the company to localized market risks, including those precipitated by the COVID-19 pandemic. Further diversifying its investment profile, Presidio holds a significant stake in Conduit Pharmaceuticals Inc., marking its entry into the life sciences sector through an equity investment in a clinical-stage, disease-agnostic life science company.
Presidio’s portfolio prominently features model homes that are leased on a triple-net basis to homebuilders within key markets in the United States, including Arizona, Illinois, Texas, Wisconsin, and Florida. These properties serve as show homes for prospective buyers, providing stable income streams from long-term leases with builders.
Apart from residential model homes, Presidio owns and manages a diverse array of commercial properties, including office spaces, industrial sites, and retail locations. The majority of these are situated in Colorado, but the portfolio extends to properties in Maryland, North Dakota, Texas, and Southern California, catering to a broad spectrum of tenants and business needs.
Expanding beyond direct real estate investments, Presidio diversifies its financial portfolio through a strategic equity stake in Conduit Pharmaceuticals Inc. This investment links Presidio to the life sciences industry, aligning it with a clinical-stage company focused on a disease-agnostic approach to drug development. Conduit Pharmaceuticals presents an innovative model for rapid compound development, offering potential growth opportunities outside of Presidio’s traditional real estate activities.